Risk of severe infections after the introduction of biologic DMARDs in people with newly diagnosed rheumatoid arthritis: a population-based interrupted time-series analysis.
Vivienne Y ZhouDiane LacailleNa LuJacek A KopecYi QianBohdan NosykJ Antonio Aviña-ZubietaJohn M EsdaileHui XiePublished in: Rheumatology (Oxford, England) (2023)
RA onset after bDMARDs introduction was associated with an elevated severe infection risk in RA patients, compared with matched non-RA individuals.